S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in
NASDAQ:FIXX

Homology Medicines Insider Trades

$10.45
-0.10 (-0.95 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.30
Now: $10.45
$10.75
50-Day Range
$10.55
MA: $12.76
$14.80
52-Week Range
$8.70
Now: $10.45
$22.38
Volume269,993 shs
Average Volume348,866 shs
Market Capitalization$473.01 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.24

Insider Trades

Homology Medicines (NASDAQ:FIXX) Insider Buying and Selling Activity

Insider Ownership Percentage: 33.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $12,860,408.15

Insider Buying and Selling by Quarter


Homology Medicines (NASDAQ FIXX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2021Timothy P KellyInsiderSell500$13.00$6,500.00500  
1/12/2021Timothy P KellyInsiderSell500$13.00$6,500.00500  
1/7/2021Albert SeymourInsiderSell15,000$12.06$180,900.00
1/5/2021Albert SeymourInsiderSell10,000$11.44$114,400.00144,017  
12/22/2020Kush ParmarDirectorSell500,000$12.82$6,410,000.00  
12/14/2020Kush ParmarDirectorSell500,000$12.25$6,125,000.00  
3/17/2020Timothy P. KellyInsiderSell1,315$13.01$17,108.15  
1/29/2020James E FlynnMajor ShareholderSell8,857$15.45$136,840.65  
1/27/2020James E FlynnMajor ShareholderSell193,359$15.77$3,049,271.43  
1/24/2020James E FlynnMajor ShareholderSell380,256$15.69$5,966,216.64  
1/2/2020Albert SeymourInsiderSell9,133$20.50$187,226.50154,017  
1/2/2020Arthur TzianabosCEOSell12,500$20.50$256,250.0090,005  
1/2/2020W Bradford SmithCFOSell6,000$20.50$123,000.006,000  
12/23/2019James E FlynnMajor ShareholderSell130,979$21.83$2,859,271.57  
12/19/2019James E FlynnMajor ShareholderSell12,622$21.68$273,644.96  
12/2/2019Albert SeymourInsiderSell9,300$16.23$150,939.00172,450  
12/2/2019Arthur TzianabosCEOSell12,500$16.25$203,125.00115,005  
12/2/2019W Bradford SmithCFOSell6,000$16.21$97,260.006,000  
11/29/2019Albert SeymourInsiderSell9,300$16.06$149,358.00172,450  
11/29/2019Arthur TzianabosCEOSell12,500$16.04$200,500.00115,005  
11/29/2019W Bradford SmithCFOSell6,000$16.00$96,000.006,000  
10/1/2019Albert SeymourInsiderSell9,300$17.39$161,727.00
10/1/2019Arthur TzianabosCEOSell12,500$17.40$217,500.00
10/1/2019W Bradford SmithCFOSell6,000$17.39$104,340.00
9/5/2019Timothy P KellyInsiderSell1,166$19.94$23,250.04
9/3/2019Albert SeymourInsiderSell9,300$18.74$174,282.00191,050  
9/3/2019Arthur TzianabosCEOSell12,500$18.75$234,375.00140,005  
9/3/2019W Bradford SmithCFOSell6,000$18.74$112,440.006,000  
8/1/2019Albert SeymourInsiderSell9,300$17.37$161,541.00200,350  
8/1/2019Arthur TzianabosCEOSell12,500$17.37$217,125.00152,505  
8/1/2019W Bradford SmithCFOSell6,000$17.37$104,220.006,000  
7/9/2019Siyamak RastyCOOSell8,000$20.00$160,000.00  
7/1/2019Albert SeymourInsiderSell9,300$18.98$176,514.00  
7/1/2019Arthur TzianabosCEOSell12,500$18.98$237,250.00  
7/1/2019W Bradford SmithCFOSell6,000$19.00$114,000.00  
6/3/2019Albert SeymourInsiderSell9,300$19.90$185,070.00  
6/3/2019Arthur TzianabosCEOSell12,500$19.86$248,250.00  
6/3/2019Siyamak RastyCOOSell8,000$20.22$161,760.00  
6/3/2019W Bradford SmithCFOSell6,000$19.94$119,640.00  
5/16/2019Kush ParmarDirectorSell615,000$21.47$13,204,050.00  
4/12/2019James E FlynnInsiderBuy533,333$22.50$11,999,992.50  
12/10/2018Kush ParmarDirectorSell15,575$26.01$405,105.75  
11/23/2018Ventures Iv L.P. 5AmMajor ShareholderSell29,682$20.04$594,827.28  
11/16/2018Ventures Iv L.P. 5AmMajor ShareholderSell525,900$20.20$10,623,180.00  
4/2/2018James E FlynnInsiderBuy1,250,000$16.00$20,000,000.00  
4/2/2018Vida Ventures, LlcMajor ShareholderBuy375,000$16.00$6,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.